JAC Advance Access originally published online on March 16, 2005
Journal of Antimicrobial Chemotherapy 2005 55(5):699-706; doi:10.1093/jac/dki086
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Modelling time–kill studies to discern the pharmacodynamics of meropenem
1 University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030; 2 University of Houston, Department of Chemical Engineering, Houston, TX, USA
* Corresponding author. Tel: +1-713-795–8316; Fax: +1-713-795-8383; Email: vtam{at}uh.edu
Objectives: Time–kill studies are commonly used in investigations of new antimicrobial agents. However, they typically provide descriptive information on pharmacodynamics. We developed a mathematical model to capture the relationship between microbial burden and antimicrobial agent concentrations.
Methods: Time–kill studies were performed with 108 cfu/mL of Pseudomonas aeruginosa at baseline. Meropenem at 0, 0.25, 1, 4, 16 and 64 x MIC was used (MIC = 1 mg/L). Serial samples were obtained to quantify bacterial burden over 24 h. The data were analysed by a population analysis using the non-parametric adaptive grid program. The rate of change of bacteria over time was expressed as the difference between linear bacterial growth rate and sigmoidal kill rate. Regrowth was attributed to adaptation, which was explicitly modelled as increase in C50k (concentration to achieve 50% maximal kill rate), using a saturable function of selective pressure (both meropenem concentration and time).
Results: The best-fit model consisted of eight parameters and the fit to the data was satisfactory. The r2 of maximum a-posteriori probability Bayesian predictions based on the mean parameter estimates was 0.984. Maximal killing rate at baseline was found to be 4.7 h–1; C90k was achieved with meropenem at 5.0 mg/L. The model was validated by time–kill studies using 2x and 32x MIC of meropenem.
Conclusions: Our model reasonably described and predicted the time course of P. aeruginosa in time–kill studies, and provided quantitative information on the pharmacodynamics of meropenem. The structural model appeared robust and could be used to provide a realistic expectation of the killing performance of antimicrobial agents.
Keywords: pharmacodynamic modelling , mathematical models , Pseudomonas aeruginosa
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kim, M. A. Banevicius, and D. P. Nicolau In Vivo Pharmacodynamic Profiling of Doripenem against Pseudomonas aeruginosa by Simulating Human Exposures Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2497 - 2502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Tam, A. N. Schilling, K. Poole, and M. Nikolaou Mathematical modelling response of Pseudomonas aeruginosa to meropenem J. Antimicrob. Chemother., December 1, 2007; 60(6): 1302 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Mouton, N. Punt, and A. A. Vinks Concentration-Effect Relationship of Ceftazidime Explains Why the Time above the MIC Is 40 Percent for a Static Effect In Vivo Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3449 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Nielsen, A. Viberg, E. Lowdin, O. Cars, M. O. Karlsson, and M. Sandstrom Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments Antimicrob. Agents Chemother., January 1, 2007; 51(1): 128 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Tam, S. Kabbara, G. Vo, A. N. Schilling, and E. A. Coyle Comparative Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2626 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Tam, A. N. Schilling, S. Neshat, K. Poole, D. A. Melnick, and E. A. Coyle Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4920 - 4927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Tam and M. Nikolaou Mathematical modelling of resistance emergence J. Antimicrob. Chemother., November 1, 2005; 56(5): 983 - 983. [Full Text] [PDF]
|
|